The U.S. Food and Drug Administration has granted regular approval to treatment with Rubraca (rucaparib) for the treatment of ...

The most common symptoms of prostate cancer are needing to urinate more often and straining to pee. Men may also feel as ...

A groundbreaking international trial investigating a robotic, AI-driven therapy for prostate cancer has launched in the UK, mark ...

A groundbreaking international trial for treating prostate cancer has launched in the UK. The trial is sponsored by US company PROCEPT BioRobotics and supported by the National Institute for Health ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.

The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ ...

Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk of side effects, a study suggests.

Francis Medical has received FDA clearance for its Vanquish water vapor ablation system for the management of prostate cancer ...

Learn about prostate cancer symptoms, diagnosis, staging and the latest treatments including robotic surgery, SBRT, radioligand therapy and targeted drugs.

Men face higher chronic disease rates after 40. Learn which medical tests doctors say are vital for preventing heart attacks, ...

A groundbreaking trial for a prostate cancer treatment with fewer side-effects has launched in the UK, researchers have said.

Profound would also like to congratulate Satoru Takahashi, MD, PhD, of Takatsuki General Hospital in Japan, for receiving a Certificate of Merit award from RSNA for his presentation titled “TULSA for ...